AviClear is the First Device Cleared for the Treatment of Mild, Moderate and Severe Acne – Not available in Europe.
Non-toxic, non-chemical, non-systemic
Safe for all skin types
High patient satisfaction
Our North American team recently presented 12-month post-treatment clinical data related to AviClear at the 42nd Annual Clinical Dermatology Conference in Las Vegas, Nevada.
Current clinical studies show that after three 30 minute treatment sessions, 90% of patients experienced visible improvement in their acne at six months. New 12-month clinical findings show this improvement increases to 92%, confirming the continual improvement of acne clearance and skin quality over time.
Studies also demonstrated that three-fourths of patients showed a 2+ IGA score improvement and two-thirds of patients were assessed as clear or almost-clear 12 months after their final treatment session.
AviClear is only currently available in North America, but for all European-based phycicians interested in this revolutionary acne treatment, please subscribe to our AviClear.eu newsletter to ensure you receive all the latest updates and information on any potential future launch first announcements
